News Focus
News Focus
icon url

catdaddy

06/18/25 10:28 PM

#492014 RE: BIOChecker4 #492013

You’re a joke!
icon url

mike_dotcom

06/19/25 7:20 AM

#492015 RE: BIOChecker4 #492013

Or perhaps we're seeing some small anticipation of approval - which, as you well know, will skyrocket the stock. Maybe that "momentum wave" will turn into a tsunami that will wipe out the shorts still clinging to the shoreline.
icon url

Citrati

06/19/25 2:14 PM

#492023 RE: BIOChecker4 #492013

Those disparaging your post simply are showing their stock performance conceptual ignorance.
Your volume analysis and comments are right on. The post is supported by fact. What one does with the fact can be buying, selling or holding.
None of those actions refute the existence of the fact that current volume is light or that more volume is needed to elevate price beyond the current resistance that could make this move another fade.
Going back to beginning of 2025 and comparing the volume for each move it is obvious what is lacking right now. The blue horizontal at 1million shares of volume is significant.
I imagine a middle schooler can look at the volume to price relationship and tell us how much volume is needed for a true breakout.

https://investorshub.advfn.com/uimage/uploads/2025/6/19/zlxgnScreen_Shot_2025-06-19_at_12.09.13_PM.png

Wish everyone green profits and success.
The world needs this.
icon url

Citrati

06/19/25 4:55 PM

#492035 RE: BIOChecker4 #492013

The behind the scenes enthusiasm is manifest in the percent of retail ownership. One thing that can account for low volume would be the vast majority of current retail as Long Term holders combined with the so far steadiness of institutions.

AI Overview
Retail investors own approximately 59% of Anavex Life Sciences Corp. (AVXL) stock. This means that individual investors, as opposed to institutional investors like mutual funds or hedge funds, hold the majority of the company's shares, according to finance websites. Institutional investors hold around 38% of the shares.
Here's a more detailed breakdown:
Retail Investors: 59%
Institutional Investors: 38%
Insider Ownership: 5.15%
Anavex Life Sciences: A Promotional Company With Too Many ...
While the exact percentage can fluctuate, these figures indicate that retail investors have a significant influence on the stock's price and movement.